Supplement
Eriocitrin clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Name
- Eriocitrin
- 3
Studies by the year they started
3 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 2 |
By phase
A phase 1/2 study counts in both.
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Studies
Open first, then newest update. How each study uses eriocitrin is read from its arms, and is right about nine times in ten.
Testing it · 3
- Effect of Eriocitrin Supplementation in Subjects With Intermediate HyperglycemiaCompletedNot applicableThais CesarNCT03215043Written as Eriocitrin
- Therapeutic Intervention of Eriocitrin in the Reduction of Hyperglycemia in Pre-diabetic IndividualsCompletedNot applicableSão Paulo State UniversityNCT03928249Written as Eriocitrin
- Supplementation of Eriocitrin in Intestinal MicrobiotaTerminatedNot applicableSão Paulo State UniversityNCT03925909Written as Eriocitrin
Codes
What other systems call eriocitrin · ClinicalTrials.gg INT004100
- MeSH (NLM) C114706eriocitrinOne source NLM
- UNII (FDA) AS293HR5XQERIOCITRINConfirmed FDA, NLM, Wikidata
- Wikidata Q13567664eriocitrinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C221991EriocitrinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C114706 | eriocitrin | One source NLM |
| UNII (FDA) | AS293HR5XQ | ERIOCITRIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q13567664 | eriocitrin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C221991 | Eriocitrin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.